Crystal structure of human PEDF, a potent anti-angiogenic and neurite growth-promoting factor.

PubWeight™: 1.15‹?› | Rank: Top 10%

🔗 View Article (PMC 58695)

Published in Proc Natl Acad Sci U S A on September 18, 2001

Authors

M Simonovic1, P G Gettins, K Volz

Author Affiliations

1: Department of Biochemistry, College of Medicine, University of Illinois, Chicago, IL 60612-7334, USA.

Articles citing this

Laminin receptor involvement in the anti-angiogenic activity of pigment epithelium-derived factor. J Biol Chem (2009) 1.36

Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization. Biochem J (2003) 1.35

The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential. Nat Rev Cancer (2013) 1.31

Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site. Proc Natl Acad Sci U S A (2004) 1.26

Polarized secretion of PEDF from human embryonic stem cell-derived RPE promotes retinal progenitor cell survival. Invest Ophthalmol Vis Sci (2011) 1.18

Codon preference optimization increases heterologous PEDF expression. PLoS One (2010) 1.10

Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin). Ocul Surf (2012) 1.08

Effects of human recombinant PEDF protein and PEDF-derived peptide 34-mer on choroidal neovascularization. Invest Ophthalmol Vis Sci (2009) 1.05

Pigment epithelium-derived factor (PEDF) prevents retinal cell death via PEDF Receptor (PEDF-R): identification of a functional ligand binding site. J Biol Chem (2013) 1.02

Pigment epithelium-derived factor binds to hyaluronan. Mapping of a hyaluronan binding site. J Biol Chem (2008) 0.96

A Chronic Fatigue Syndrome - related proteome in human cerebrospinal fluid. BMC Neurol (2005) 0.96

The applied biochemistry of PEDF and implications for tissue homeostasis. Growth Factors (2010) 0.88

Glycosaminoglycans in human retinoblastoma cells: heparan sulfate, a modulator of the pigment epithelium-derived factor-receptor interactions. BMC Biochem (2003) 0.87

Molecular phylogeny of the antiangiogenic and neurotrophic serpin, pigment epithelium derived factor in vertebrates. BMC Genomics (2006) 0.84

Serpin-derived peptides are antiangiogenic and suppress breast tumor xenograft growth. Transl Oncol (2012) 0.82

PEDF - A Noninhibitory Serpin with Neurotrophic Activity. Acta Naturae (2010) 0.80

Pigment epithelium-derived factor (PEDF) interacts with transportin SR2, and active nuclear import is facilitated by a novel nuclear localization motif. PLoS One (2011) 0.80

Pigment epithelium-derived factor (PEDF) shares binding sites in collagen with heparin/heparan sulfate proteoglycans. J Biol Chem (2011) 0.79

Identification of pigment epithelium-derived factor protein forms with distinct activities on tumor cell lines. J Biomed Biotechnol (2012) 0.79

Priorities and trends in the study of proteins in eye research, 1924-2014. Proteomics Clin Appl (2015) 0.78

Analysis of three pigment epithelium-derived factor gene polymorphisms in patients with exudative age-related macular degeneration. Mol Vis (2009) 0.78

Expression of SERPINA3s in cattle: focus on bovSERPINA3-7 reveals specific involvement in skeletal muscle. Open Biol (2015) 0.76

Pigment epithelium-derived factor as a multifunctional regulator of wound healing. Am J Physiol Heart Circ Physiol (2015) 0.76

Anti-tumor effects of pigment epithelium-derived factor (PEDF): implication for cancer therapy. A mini-review. J Exp Clin Cancer Res (2016) 0.75

1.45 Å resolution structure of SRPN18 from the malaria vector Anopheles gambiae. Acta Crystallogr F Struct Biol Commun (2016) 0.75

Pigment epithelium-derived factor: clinical significance in estrogen-dependent tissues and its potential in cancer therapy. Iran J Basic Med Sci (2015) 0.75

Secretion of N- and O-linked Glycoproteins from 4T1 Murine Mammary Carcinoma Cells. Int J Med Sci (2016) 0.75

Comparison of two neurotrophic serpins reveals a small fragment with cell survival activity. Mol Vis (2017) 0.75

Articles cited by this

Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28

Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins (1991) 36.69

Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res (1988) 32.89

Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science (1999) 5.53

Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins. Biochemistry (1989) 3.18

PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res (1991) 2.71

Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc Natl Acad Sci U S A (2001) 1.83

Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop. J Biol Chem (1995) 1.66

Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest Ophthalmol Vis Sci (1989) 1.63

Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity. J Neurosci (1995) 1.55

Spontaneous corneal neovascularization in nude mice. Local imbalance between angiogenic and anti-angiogenic factors. Invest Ophthalmol Vis Sci (1993) 1.41

Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 A and full insertion of the reactive center loop into beta-sheet A. Proc Natl Acad Sci U S A (1999) 1.41

Pigment epithelium-derived factor delays the death of photoreceptors in mouse models of inherited retinal degenerations. Neurobiol Dis (1999) 1.40

Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin. Mol Vis (1996) 1.36

Binding of pigment epithelium-derived factor (PEDF) to retinoblastoma cells and cerebellar granule neurons. Evidence for a PEDF receptor. J Biol Chem (1999) 1.35

Pigment epithelium-derived factor supports normal development of photoreceptor neurons and opsin expression after retinal pigment epithelium removal. J Neurosci (2000) 1.31

Pigment epithelium-derived factor promotes the survival and differentiation of developing spinal motor neurons. J Comp Neurol (1999) 1.27

Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide-induced cell death. J Neurosci Res (1999) 1.26

Pigment epithelium-derived factor is a survival factor for cerebellar granule cells in culture. J Neurochem (1995) 1.16

Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration. J Neuropathol Exp Neurol (1999) 1.15

Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site. Biochemistry (1998) 1.12

Senescent WI-38 cells fail to express EPC-1, a gene induced in young cells upon entry into the G0 state. J Biol Chem (1993) 1.08

Pigment epithelium-derived factor protects cultured cerebellar granule cells against glutamate-induced neurotoxicity. J Neurochem (1997) 1.05

Recombinant human pigment epithelium-derived factor (PEDF): characterization of PEDF overexpressed and secreted by eukaryotic cells. Protein Sci (1996) 1.04

Gene expression of the neurotrophic pigment epithelium-derived factor in the human ciliary epithelium. Synthesis and secretion into the aqueous humor. Invest Ophthalmol Vis Sci (1996) 0.98

Differentiation of Y79 retinoblastoma cells with pigment epithelial-derived factor and interphotoreceptor matrix wash: effects on tumorigenicity. Growth Factors (1994) 0.96

Neuroprotection by pigment epithelial-derived factor against glutamate toxicity in developing primary hippocampal neurons. J Neurosci Res (1999) 0.96

Proteolytic activity directed toward pigment epithelium-derived factor in vitreous of bovine eyes. Implications of proteolytic processing. Invest Ophthalmol Vis Sci (1996) 0.95

Serpin conformational change in ovalbumin. Enhanced reactive center loop insertion through hinge region mutations. Biochemistry (1997) 0.93

Pigment epithelium-derived factor (PEDF) has direct effects on the metabolism and proliferation of microglia and indirect effects on astrocytes. J Neurosci Res (1997) 0.91

PEDF: Raising both hopes and questions in controlling angiogenesis. Proc Natl Acad Sci U S A (2001) 0.87

Regulation of EPC-1/PEDF in normal human fibroblasts is posttranscriptional. J Cell Biochem (2000) 0.81

Articles by these authors

The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem (2001) 4.81

A chemotactic signaling surface on CheY defined by suppressors of flagellar switch mutations. J Bacteriol (1992) 1.63

A distinct meta-active conformation in the 1.1-A resolution structure of wild-type ApoCheY. J Biol Chem (2001) 1.52

Tyrosine 106 of CheY plays an important role in chemotaxis signal transduction in Escherichia coli. J Bacteriol (1996) 1.49

Pathogenic alpha 1-antitrypsin polymers are formed by reactive loop-beta-sheet A linkage. J Biol Chem (2000) 1.43

Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 A and full insertion of the reactive center loop into beta-sheet A. Proc Natl Acad Sci U S A (1999) 1.41

Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding. Biochemistry (1996) 1.35

Crystal structures of CheY mutants Y106W and T87I/Y106W. CheY activation correlates with movement of residue 106. J Biol Chem (1997) 1.31

Major proteinase movement upon stable serpin-proteinase complex formation. Proc Natl Acad Sci U S A (1997) 1.31

NMR solution structure of complement-like repeat CR3 from the low density lipoprotein receptor-related protein. Evidence for specific binding to the receptor binding domain of human alpha(2)-macroglobulin. J Biol Chem (2000) 1.24

The 1.9 A resolution crystal structure of phosphono-CheY, an analogue of the active form of the response regulator, CheY. Biochemistry (2000) 1.21

NMR solution structure of complement-like repeat CR8 from the low density lipoprotein receptor-related protein. J Biol Chem (1999) 1.19

Uncoupled phosphorylation and activation in bacterial chemotaxis. The 2.1-A structure of a threonine to isoleucine mutant at position 87 of CheY. J Biol Chem (1995) 1.16

Alpha 1-proteinase inhibitor variant T345R. Influence of P14 residue on substrate and inhibitory pathways. Biochemistry (1994) 1.15

The CheZ-binding surface of CheY overlaps the CheA- and FliM-binding surfaces. J Biol Chem (1997) 1.13

Uncoupled phosphorylation and activation in bacterial chemotaxis. The 2.3 A structure of an aspartate to lysine mutant at position 13 of CheY. J Biol Chem (1997) 1.08

Calcium coordination and pH dependence of the calcium affinity of ligand-binding repeat CR7 from the LRP. Comparison with related domains from the LRP and the LDL receptor. Biochemistry (2001) 1.08

Deconvolution of the fluorescence emission spectrum of human antithrombin and identification of the tryptophan residues that are responsive to heparin binding. J Biol Chem (1998) 1.06

Recombinant human pigment epithelium-derived factor (PEDF): characterization of PEDF overexpressed and secreted by eukaryotic cells. Protein Sci (1996) 1.04

The conformational activation of antithrombin. A 2.85-A structure of a fluorescein derivative reveals an electrostatic link between the hinge and heparin binding regions. J Biol Chem (2000) 1.03

Mechanism of acceleration of antithrombin-proteinase reactions by low affinity heparin. Role of the antithrombin binding pentasaccharide in heparin rate enhancement. J Biol Chem (1995) 1.02

Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin. Biochemistry (1998) 1.01

Mapping the serpin-proteinase complex using single cysteine variants of alpha1-proteinase inhibitor Pittsburgh. J Biol Chem (1998) 0.99

Role of arginine 132 and lysine 133 in heparin binding to and activation of antithrombin. J Biol Chem (1996) 0.99

High-level bacterial expression and 15N-alanine-labeling of bovine trypsin. Application to the study of trypsin-inhibitor complexes and trypsinogen activation by NMR spectroscopy. Biochemistry (2001) 0.97

Serine 380 (P14) --> glutamate mutation activates antithrombin as an inhibitor of factor Xa. J Biol Chem (2000) 0.97

Role of calcium in protein folding and function of Tva, the receptor of subgroup A avian sarcoma and leukosis virus. J Virol (2001) 0.95

Critical role of the linker region between helix D and strand 2A in heparin activation of antithrombin. J Biol Chem (2000) 0.94

Serpin conformational change in ovalbumin. Enhanced reactive center loop insertion through hinge region mutations. Biochemistry (1997) 0.93

Formation of a noncovalent serpin-proteinase complex involves no conformational change in the serpin. Use of 1H-15N HSQC NMR as a sensitive nonperturbing monitor of conformation. Biochemistry (2000) 0.91

Insight into the mechanism of serpin-proteinase inhibition from 2D [1H-15N] NMR studies of the 69 kDa alpha 1-proteinase inhibitor Pittsburgh-trypsin covalent complex. Biochemistry (2001) 0.90

NMR solution structure of the receptor binding domain of human alpha(2)-macroglobulin. J Biol Chem (2000) 0.90

On the structural changes of native human alpha2-macroglobulin upon proteinase entrapment. Three-dimensional structure of the half-transformed molecule. J Biol Chem (1998) 0.89

S-ovalbumin, an ovalbumin conformer with properties analogous to those of loop-inserted serpins. Protein Sci (1995) 0.87

Localization of basic residues required for receptor binding to the single alpha-helix of the receptor binding domain of human alpha2-macroglobulin. Protein Sci (1998) 0.86

Significance of secondary structure predictions on the reactive center loop region of serpins: a model for the folding of serpins into a metastable state. FEBS Lett (1996) 0.86

Antithrombin-heparin affinity reduced by fucosylation of carbohydrate at asparagine 155. Biochemistry (1996) 0.86

Importance of the P2 glycine of antithrombin in target proteinase specificity, heparin activation, and the efficiency of proteinase trapping as revealed by a P2 Gly --> Pro mutation. J Biol Chem (1999) 0.85

Characterization of the calcium site in two complement-like domains from the low-density lipoprotein receptor-related protein (LRP) and comparison with a repeat from the low-density lipoprotein receptor. Biochemistry (1998) 0.85

The P6-P2 region of serpins is critical for proteinase inhibition and complex stability. Biochemistry (1997) 0.84

Change in environment of the P1 side chain upon progression from the Michaelis complex to the covalent serpin-proteinase complex. Biochemistry (1998) 0.81

The structure of the C949S mutant human alpha(2)-macroglobulin demonstrates the critical role of the internal thiol esters in its proteinase-entrapping structural transformation. J Struct Biol (2000) 0.79

Linkage between the hormone binding site and the reactive center loop of thyroxine binding globulin. Arch Biochem Biophys (2000) 0.79

Bait region involvement in the dimer-dimer interface of human alpha 2-macroglobulin and in mediating gross conformational change. Evidence from cysteine variants that form interdimer disulfides. J Biol Chem (1998) 0.79

Crystal structure of viral serpin crmA provides insights into its mechanism of cysteine proteinase inhibition. Protein Sci (2000) 0.79

Carbohydrate isoforms of antithrombin variant N135Q with different heparin affinities. FEBS Lett (1993) 0.78

The mechanism by which serpins inhibit thrombin and other serine proteinases. Ann N Y Acad Sci (1994) 0.78

Protein C activators from snake venoms and their diagnostic use. Haemostasis (2002) 0.78

Conformational equilibrium of the reactive center loop of antithrombin examined by steady state and time-resolved fluorescence measurements: consequences for the mechanism of factor Xa inhibition by antithrombin-heparin complexes. Biochemistry (2001) 0.77

Crystallization and preliminary X-ray diffraction analysis of a recombinant cysteine-free mutant of crmA. Acta Crystallogr D Biol Crystallogr (2000) 0.77

Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants. Biochemistry (1994) 0.76

Crystallization and preliminary characterization of CheY, a chemotaxis control protein from Escherichia coli. J Biol Chem (1986) 0.76

Crystallization and preliminary X-ray analysis of FlhD from Escherichia coli. J Struct Biol (1998) 0.75

Serpins are suicide substrates: implications for the regulation of proteolytic pathways. Semin Thromb Hemost (1994) 0.75

Antithrombin histidine variants 1H NMR resonance assignments and functional properties. FEBS Lett (1994) 0.75

Critical role of asparagine 1065 of human alpha2-macroglobulin in formation and reactivity of the thiol ester. J Biol Chem (1997) 0.75

Characterization of solar cells by photocurrent spectroscopy and current-voltage characteristics with high spatial resolution. Opt Express (2010) 0.75

A database of recombinant wild-type and mutant serpins. Thromb Haemost (1994) 0.75

Structural details of proteinase entrapment by human alpha2-macroglobulin emerge from three-dimensional reconstructions of Fab labeled native, half-transformed, and transformed molecules. J Biol Chem (1999) 0.75

Comparison of Limulus alpha-macroglobulin with human alpha2-macroglobulin: thiol ester characterization, subunit organization, and conformational change. Arch Biochem Biophys (1997) 0.75

Tuning the magnetic properties of GaAs:Mn/MnAs hybrids via the MnAs cluster shape. J Phys Condens Matter (2006) 0.75